This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.




Stimunity develops immuno-stimulatory biological drugs in oncology. The company is a spin-off of Institut Curie (Paris, France) exploiting a Virus-Like Particle cutting-edge technology to stimulate the immune system against tumor cells via the STING pathway. Unlike competition, we achieve a potent immune response, a synergy with immune checkpoint inhibitors and a therapeutic efficacy on distant tumors.

Presenter: Sylvain Carlioz, CEO, Stimunity